In drug development, a covered clinical study refers to a clinical study, submitted to the Food and Drug Administration (FDA) as part of a marketing application (for example, as part of an NDA), about which the FDA may require disclosure of financial interest of the clinical investigator in the outcome of the study. For example, the applicant must disclose whether an investigator owns equity in the sponsor, or owns proprietary interest in the product under investigation.
The FDA defines a covered study as "...any study of a drug, biological product or device in humans submitted in a marketing application or reclassification petition that the applicant or FDA relies on to establish that the product is effective (including studies that show equivalence to an effective product) or any study in which a single investigator makes a significant contribution to the demonstration of safety."
Famous quotes containing the words covered and/or study:
“King David was old and advanced in years; and although they covered him with clothes, he could not get warm.”
—Bible: Hebrew, 1 Kings 1:1.
“Surely the one thing needful for a Christian and an Englishman to study is Christian and moral and political philosophy, and then we should see our way a little more clearly without falling into Judaism, or Toryism, or Jacobinism, or any other ism whatever.”
—Thomas Arnold (1795–1842)